Showing 1 - 3 results of 3 for search 'James Resau', query time: 0.02s Refine Results
  1. 1
    Cytokine receptor-like factor 1 (CRLF1) protects against 6-hydroxydopamine toxicity independent of the gp130/JAK signaling pathway.

    Cytokine receptor-like factor 1 (CRLF1) protects against 6-hydroxydopamine toxicity independent of the gp130/JAK signaling pathway. by Brendan D Looyenga, James Resau, Jeffrey P MacKeigan

    Published 2013-01-01
    Get full text
    Article
  2. 2
    Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway.

    Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway. by Brendan D. Looyenga, James Resau, Jeffrey P. MacKeigan

    Published 2014-01-01
    Get full text
    Article
  3. 3
    Met kinetic signature derived from the response to HGF/SF in a cellular model predicts breast cancer patient survival.

    Met kinetic signature derived from the response to HGF/SF in a cellular model predicts breast cancer patient survival. by Gideon Y Stein, Nir Yosef, Hadar Reichman, Judith Horev, Adi Laser-Azogui, Angelique Berens, James Resau, Eytan Ruppin, Roded Sharan, Ilan Tsarfaty

    Published 2012-01-01
    Get full text
    Article

Search Tools: